Stevenage Bioscience Catalyst
Edit

Stevenage Bioscience Catalyst

https://www.stevenagecatalyst.com
Last activity: 09.12.2021
Stevenage Bioscience Catalyst is a leading location for companies to develop and commercialise cutting edge therapeutics. The Campus is home to major organisations including GSK, the Cell & Gene Therapy Manufacturing Catapult, LifeArc and GE alongside a growing cluster of academics and start-up companies which together have raised over £1bn in funding. The facilities have been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs. Access is offered to business support, equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies.
Mentions
12
Location: United Kingdom, England, Stevenage
Employees: 1-10
Founded date: 2012
Investment Type: Accelerator

Mentions in press and media 12

DateTitleDescriptionSource
02.03.2022Stevenage Bioscience Catalyst launches accelerator programme...Stevenage Bioscience Catalyst (SBC) launches an accelerator programme to give start-ups working on d...cambridgen...
09.12.2021Report demonstrates Stevenage Bioscience Catalyst’s key role...Report demonstrates Stevenage Bioscience Catalyst’s key role in delivering the economic benefit from...cambridgen...
18.11.2021Biotech start-ups successfully graduate from DATA accelerato...Biotech start-ups successfully graduate from DATA accelerator programme at Stevenage Bioscience Cata...cambridgen...
23.02.2021Stevenage Bioscience Catalyst launches accelerator programme...Stevenage Bioscience Catalyst launches accelerator programme for biotech start-ups 23-02-2021 Stev...cambridgen...
03.01.2021Dr Sally Ann Forsyth CEO Stevenage Bioscience Catalyst award...Dr Sally Ann Forsyth CEO Stevenage Bioscience Catalyst awarded OBE 03-01-2021 Dr Sally Ann Forsyth...cambridgen...
24.11.2020Stevenage Bioscience Catalyst opens the Lab HotelStevenage Bioscience Catalyst opens the Lab Hotel 24-11-2020 Stevenage Bioscience Catalyst (SBC), ...cambridgen...
01.09.2020SBC company ReViral raises $44 million in Series C financingSBC company ReViral raises $44 million in Series C financing 01-09-2020 London & Research Tria...cambridgen...
05.01.2017NeRRe Therapeutics Raises £23M in Series B FinancingNeRRe Therapeutics, a Stevenage, England, UK-based clinical-stage company, raised £23m in Series B f...finsmes.co...
16.10.2013MRC Technology to join innovation network at Stevenage Biosc...MRC Technology to join innovation network at Stevenage Bioscience Catalyst 16-10-2013 Stevenage Bi...cambridgen...
30.09.2013Learn about biobusiness innovation in a clusterLearn about biobusiness innovation in a cluster 30-09-2013 Hear Jane Osbourn, Site Leader, Vice Pr...cambridgen...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In